Tetrahydrocannabinol (THC)

Monitoring Medical Cannabis

January 26, 2018

Giuseppe Cannazza and Cinzia Citti from the University of Modena and Reggio Emilia discuss the growing interest in the use of medicinal cannabis in Europe and the analytical challenges involved.

GW Pharmaceuticals Announces Results from Cancer Trial

February 13, 2017

On Feb. 7, 2017 GW Pharmaceuticals announced the results from a small Phase II study with tetrahydrocannabinol (THC) and cannabidiol (CBD) in 21 patients with recurrent glioblastoma multiforme (GBM).